ANNOUNCEMENT 01 Jun 2021
India has imposed a licensing requirement on exports of an antifungal medication.
NUMBER OF INTERVENTIONS
Notification No. 07/2015-2020
On 1 June 2021, the Indian Directorate General of Foreign Trade through Notification No. 07/2015-2020 amended the export policy of Amphotericin-B injections from "Free" to "Restricted". Goods with a "Restricted" export policy will require applying for a license before exports.
Amphotericin B is an antifungal medication that has seen an increase in demand in India due to fungal infections in COVID-19 patients.